PMID- 21156725 OWN - NLM STAT- MEDLINE DCOM- 20110426 LR - 20161125 IS - 1460-2350 (Electronic) IS - 0268-1161 (Linking) VI - 26 IP - 2 DP - 2011 Feb TI - Thrombin-induced chemokine production in endometrial stromal cells. PG - 407-13 LID - 10.1093/humrep/deq347 [doi] AB - BACKGROUND: In order to investigate the regulation of chemokines [interleukin-8 (IL-8), growth-regulated oncogene (GRO)alpha, monocyte chemoattractant protein-1 (MCP-1)) induced by thrombin in endometrial stromal cells (ESCs), the effects of thrombin, a protease activated receptor (PAR)-1 antagonist (PPACK), mitogen-activated protein kinase kinase inhibitor (U0126), phospholipase C inhibitor (U-73122), an antagonist of the intracellular InsP3 receptor (2-aminoethoxy-diphenylborate (2-APB)] and a protein kinase C inhibitor (GF-109203X) on the production of chemokines by ESCs were evaluated. METHODS: ESCs from eight endometrial specimens in the secretory phase were cultured and incubated for 24h with thrombin and PPACK, U0126, U-73122, 2-APB or GF-109203X. The levels of IL-8, GROalpha and MCP-1 in the culture medium were measured by means of ELISA. The activation of MAP kinase was detected by western blot analysis using anti-phosphorylated MAP kinase (ERK1/2) antibody. RESULTS: Following stimulation by thrombin, the production of IL-8, GROalpha and MCP-1 increased significantly in a dose-dependent manner. PPACK, U0126, U-73122, 2-APB or GF-109203X suppressed the increases in production of IL-8, GROalpha and MCP-1 induced by thrombin (P < 0.001, P <0.001 and P <0.001, respectively). MAP kinase activities were induced by treatment with thrombin, and were suppressed by PPACK, U0126, U-73122, 2-APB or GF-109203X. CONCLUSIONS: Our results suggest that thrombin stimulates the production of IL-8, GROalpha and MCP-1 via PAR-1 by a mechanism involving the MAP kinase system. The increases in IL-8, GROalpha and MCP-1 may contribute to the maintenance of implantation involving leukocyte chemotaxis. FAU - Kawano, Yasushi AU - Kawano Y AD - Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan. kawayas@oita-u.ac.jp FAU - Furukawa, Yuichi AU - Furukawa Y FAU - Kawano, Yukie AU - Kawano Y FAU - Nasu, Kaei AU - Nasu K FAU - Narahara, Hisashi AU - Narahara H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101214 PL - England TA - Hum Reprod JT - Human reproduction (Oxford, England) JID - 8701199 RN - 0 (Amino Acid Chloromethyl Ketones) RN - 0 (Boron Compounds) RN - 0 (Butadienes) RN - 0 (CXCL1 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CXCL1) RN - 0 (Estrenes) RN - 0 (Indoles) RN - 0 (Interleukin-8) RN - 0 (Maleimides) RN - 0 (Nitriles) RN - 0 (Pyrrolidinones) RN - 0 (Receptor, PAR-1) RN - 0 (U 0126) RN - 112648-68-7 (1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) RN - E4ES684O93 (2-aminoethoxydiphenyl borate) RN - EC 3.4.21.5 (Thrombin) RN - L79H6N0V6C (bisindolylmaleimide I) RN - N62UL02WW4 (phenylalanyl-prolyl-arginine-chloromethyl ketone) SB - IM MH - Adult MH - Amino Acid Chloromethyl Ketones/pharmacology MH - Boron Compounds/pharmacology MH - Butadienes/pharmacology MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis MH - Chemokine CXCL1/biosynthesis MH - Endometrium/cytology MH - Estrenes/pharmacology MH - Female MH - Humans MH - Indoles/pharmacology MH - Interleukin-8/*biosynthesis MH - Maleimides/pharmacology MH - Nitriles/pharmacology MH - Pyrrolidinones/pharmacology MH - Receptor, PAR-1/antagonists & inhibitors MH - Stromal Cells/drug effects/*metabolism MH - Thrombin/*pharmacology EDAT- 2010/12/16 06:00 MHDA- 2011/04/27 06:00 CRDT- 2010/12/16 06:00 PHST- 2010/12/16 06:00 [entrez] PHST- 2010/12/16 06:00 [pubmed] PHST- 2011/04/27 06:00 [medline] AID - deq347 [pii] AID - 10.1093/humrep/deq347 [doi] PST - ppublish SO - Hum Reprod. 2011 Feb;26(2):407-13. doi: 10.1093/humrep/deq347. Epub 2010 Dec 14.